Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma Biogen posted strong Q4 results, surpassing estimates, while forecasting a 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback